Organization: Health Canada
Year: 2021
Month: December
Request Number: A-2021-000118
Request Summary: All documents up to May 2nd, 2021 between Novavax Inc and Health Canada with regard to the Novavax COVID-19 vaccine, also known as NVX-CoV2373, also known as SARS-CoV-2 rS (recombinant spike) protein nanoparticle vaccine with Matrix-M1 adjuvant.
Disposition: Disclosed in part
Number of pages: 429